Journal details
CANCER GENE THERAPY
SPRINGERNATURE · ISSN 0929-1903 · eISSN 1476-5500
SCIEScopusMEDLINEPubMedPMC
Overview
CANCER GENE THERAPY. ISSN 0929-1903 · eISSN 1476-5500. published by SPRINGERNATURE. England. Biotechnology & Applied Microbiology · Oncology · Genetics & Heredity. impact factor 6.4 (2025). JCR Q1. CAS Zone 3. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 47 articles · 2025: 131 articles · 2024: 146 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of CANCER GENE THERAPY?
The impact factor recorded for CANCER GENE THERAPY is 6.4 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of CANCER GENE THERAPY?
CANCER GENE THERAPY is listed in CAS Zone 3.
Which databases index CANCER GENE THERAPY?
CANCER GENE THERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.